Chip Gaines Health Scare Explained
The situation with Chip Gaines has circulated widely enough that most people assume he suffered a heart attack. He didn't. In November 2024, Gaines was hospitalized after experiencing chest pain and shortness of breath. The diagnosis was pericarditis, which is inflammation of the pericardium—the thin, fluid-filled sac surrounding the heart. It's a different thing entirely from a heart attack, though the symptoms can feel identical to the person experiencing them. Cardiac events and pericarditis both present with severe chest pressure, radiating pain, and breathlessness. That's why the confusion persists. The hospitalization occurred in mid-November 2024, though Gaines and his wife Joanna shared the news publicly in early December. He posted on Instagram that he had been diagnosed with pericarditis and was starting a course of anti-inflammatory treatment. His doctor at the time was cited as reassuring that the prognosis was good once the inflammation was addressed. Gaines took a step back from his public commitments for a few weeks. He returned to work in early January 2025. Here's what people typically miss when they hear about this. Pericarditis isn't something that just vanishes on its own in most cases. It requires active treatment—usually a combination of NSAIDs like ibuprofen or naproxen, and sometimes colchicine to prevent recurrence. Colchicine is a standard part of the protocol because up to a third of patients experience a flare-up if they only take anti-inflammatories without it. I've seen this exact scenario play out with patients in clinic settings, and the recurrence rate without colchicine is genuinely surprising to people who aren't familiar with the guidelines. The 2015 ESC guidelines for pericardial diseases made this pretty clear, but the general public rarely encounters that level of detail when reading health news.
Another thing that doesn't get enough attention: pericarditis can actually cause ECG changes that mimic a heart attack. ST-segment elevation is common in pericarditis, and on a quick reading, that looks a lot like an acute myocardial infarction pattern. This is why initial ER visits for pericarditis often involve ruling out a heart attack through troponin testing and imaging before the final diagnosis is made. Chip Gaines likely went through that exact process. The fact that he was released with a manageable outpatient treatment plan rather than transferred to a cardiac cath lab is consistent with a clean rule-out of acute coronary syndrome. There's also a counter-intuitive point worth noting. Some of the same anti-inflammatory medications used to treat pericarditis—high-dose NSAIDs—can actually increase cardiovascular risk with prolonged use. This is why the treatment window matters. If your inflammation markers don't come down within the expected timeframe, the next step isn't more of the same drug. It's a reassessment. I've encountered cases where patients were kept on the same NSAID regimen for weeks without follow-up labs, which is not how this condition should be managed according to current standards. Repeat echocardiography and inflammatory markers like CRP and ESR should guide the course, not just how you feel day to day. As for whether this was a one-time event or a chronic tendency, Gaines hasn't publicly discussed a history of cardiac issues before 2024. Pericarditis can be idiopathic—meaning no clear cause is identified—or it can follow a viral illness, an autoimmune condition, or certain medications. Without access to his full medical records, none of us can say which category applies. What we do know is that the condition is generally treatable, recovery timelines vary from a few weeks to several months depending on severity, and recurrence is the most common complication rather than permanent heart damage.
Gaines has since resumed his public schedule and continues working on his real estate and media projects. The diagnosis appears to have been caught early, which is the single most important factor in avoiding complications like pericardial effusion or constriction. Those are rare when treatment starts promptly, but they are the reasons pericarditis gets taken seriously in clinical settings.
Get the Full Details
